Objective: we present the findings of a grounded theory study designed to gain a critical understanding of the experience of side effects of treatment for HIV. Method: this study was undertaken in Canada's capital region with 50 participants through a questionnaire. Data analysis began with the initial line-by-line coding of key interviews. After it were categorized. Results: three main categories emerged from the data: the side effects, the experience, and the connections. Conclusion: the first category suggests that we need to change how we think about side effects in order to take into account the context in which they are experienced as well as the types and nature of side effects. The second category puts forward the idea that the experience of side effects is composed of three interrelated processes: becoming with, living with, and dealing with. Finally, the third category points to new connections that are formed with people, things and systems in the presence of side effects.
Introduction
Despite the availability of new (and supposedly less toxic) antiretroviral drugs in industrialized countries and the simplification of treatment options (i.e., all-in-one combination tablets such as Atripla®), side effects continue to affect people living with HIV (PLWH) (1) (2) (3) (4) . Short term and long term side effects are well documented in PLWH, although at present, it remains difficult to determine exactly how many people experience side effects and what side effects are most commonly reported.
(2) Short term side effects typically include gastrointestinal toxicities (e.g., diarrhea, nausea, vomiting, and bloating), central nervous system toxicities (e.g., vivid dreams, offbalance or unsteady walking, light-headedness, drowsiness, feeling "hungover", feeling like falling over, spinning or room spinning, difficulty concentrating), fatigue, anemia, hypersensitivity reactions, and drug-induced organ toxicities.
Short term side effects can dissipate on their own after weeks and months of treatment, but they can also persist over time and have longlasting effects on PLWH. Long term side effects include cardiovascular, hepatic, renal, metabolic, neurologic, and musculoskeletal events such as myocardial infarction, hepatotoxicity, renal dysfunction, dyslipidemia, insulin resistance, diabetes, lipodystrophy, distal sensory peripheral neuropathy, cognitive deficits, and bone loss. (2) In addition to the common side effects listed above, each antiretroviral drug currently available has a unique side effect profile and a comprehensive list of potential drug-drug interactions (4) .
The experience of developing and not being able to manage side effects is one of the most frequent reasons for treatment discontinuation or switch (5) . In fact, it is estimated that up to 25% of PLWH will stop their treatment within the first 8 months because of side effects, poor treatment adherence and / or treatment failure (i.e., inability to suppress HIV viral replication to below the current limit of detection, 40 copies/ mL) (6) . Side effects are known to contribute to poor adherence by making it harder to take antiretroviral drugs (7) . For PLWH, poor adherence can have serious consequences by compromising HIV-related outcomes (e.g., viral
load suppression, CD4 cell count, progression to AIDS, and survival) and increasing the likelihood of developing a resistance to antiretroviral drugs which, in turn, can lead to treatment failure (7) . Side effects are also known to impact quality of life. In a cohort of 2066 participants,
of which approximately two-thirds (66%) had side effects, researchers found that side effects were associated with a substantial decrement in quality of life -comparable to the decrement of homelessness (8) . For the majority of PLWH, taking antiretroviral drugs is "a trade-off between poorer quality of life and being alive" (9:252) . At times, this trade-off is not sufficient for PLWH to keep taking these drugs and make sure they take them as prescribed. In this sense, side effects and their impact on quality of life can act as a powerful barrier to treatment adherence and treatment continuation.
To date, there has been very limited qualitative research on the experience of side effects from the perspectives of PLWH. Explorative and descriptive studies published to date are almost exclusively focused on treatment adherence (for an example, see (10) ). Studies conducted on treatment adherence typically do not explore the experience of side effects per se but rather how that experience shapes the decisions and perceptions of patients who choose to switch or discontinue their prescribed treatment (11) .
Although these studies highlight that treatment adherence or non-adherence occur in a particular context and in the face of particular conditions (10) , they do not provide insight into the experience of side effects. This is also true of studies conducted on quality of life, most of which refer to the experience of side effects as a way to challenge the assumption that antiretroviral treatment (as a whole) is now simpler, more manageable, better tolerated, less toxic, and more effective. As Wong and Ussher (12) point out, this assumption is part of "a grand narrative about the lived experiences of PLWH that has the potential to marginalize Marilou Gagnon, Dave Holmes the subjective experiences of those for whom HIV, and its related monitoring practices and treatments, continue to be sources of concern and causes of distress" (12:128) . As such, it fails to take into account that living with the treatment is "not just about living longer" (12:117) ; it is also about living healthier and at a higher quality of life.
Side effects are central to the experience of living with the treatment but rarely have they been studied alone. (for example, see (13) (14) (15) (16) ) Unlike other aspects of that experience, like quality of life (12) , treatment adherence (17) , health (18) and the imperative of achieving "good results" (12, (18) (19) (20) , side effects have not benefited from the same level of empirical and theoretical engagement from scholars. In this paper, we present the findings of a grounded theory study on the experience of side effects. This two-year study was designed to: 1) gain a critical understanding of the experience of side effects; 2) explore an alternative approach that takes account of the multiple connections between the body and antiretroviral drugs; and 3) describe to what extent these connections constitute an important aspect of daily experiences and allow for more connections to be formed (with medicine, public health, nursing, community-based organizations, pharmaceutical companies, and so forth). For the purpose of this paper, we will primarily focus on the first objective of the study. The second and third objectives of the study will be discussed in a subsequent publication. Following a brief overview of the methodological considerations and sample, we will present a detailed overview of the study findings. Lastly, we will discuss the implications of the findings and some key recommendations.
Methodological Considerations
This study followed the methodological principles of grounded theory as defined by Charmaz (21, 22) . We opted for the work of Charmaz (21, 22) because it is consistent with the constructivist paradigm as opposed to other methodological traditions within grounded theory. Constructivist grounded theory starts with the assumption that social reality is multiple, processual, and constructed. (22) This particular tradition of grounded theory stresses that social reality arises within a particular situation (22) . In order to gain a deeper understanding of the research phenomenon, researchers need to look at the total situation; that is, to look at the broader context in which the phenomenon is taking place and how that impacts the way people view their experiences, how they name things, what they know, how they know, and the actions they take (22) . Constructivist grounded theory offers a set of flexible yet rigorous methods that focus on the importance of gathering rich data and analyzing the stories of participants through an analytic process "that emphasizes understanding rather than explanation" (21:126) . In fact, the goal of constructivist grounded theory is not to produce an empirical generalization of the studied phenomenon in the form of a theory.
Instead, the goal is to conceptualize the studied phenomenon in ways that reflect the interpretive (and subjective) nature of the analysis and provide theoretical openings. As such, the end product of theorizing can range from a complex substantive theory to the development of new categories or concepts (22) .
This study was undertaken in Canada's capital region. This region includes the city of Ottawa (Ontario), the city of Gatineau (Quebec), and their surrounding urban and rural communities.
Together, the province of Ontario and Quebec account for 65.9% of PLWH in Canada (23) .
After obtaining ethics approval from the Research
Ethics Board at the University of Ottawa, we distributed using posters and recruitment cards in community-based organizations and specialized clinics in Ottawa and Gatineau. In order to be included in the study, participants had to self-identify as persons living with HIV and be able to communicate in French or English. All participants had to be 18 years old or older. Participants were be eligible to take part in the study if they were taking antiretroviral drugs or confirmed that they had been taking antiretroviral drugs less than 6 months ago. The goal was to include participants who could speak we did not undertake theoretical sampling.
As highlighted by Birks and Mills (24) , this form of sampling is not always possible due to the availability of participants and other access and logistic issues.
A purposive sampling strategy was used to recruit 50 participants. Data saturation was achieved after 35 interviews. We conducted 15 additional interviews to ensure that saturation had been completely achieved.
After completing the informed consent process, each participant was asked to fill out a short questionnaire which will include sociodemographic data, basic clinical information and a checklist of side effects. A summary of the socio-demographic and clinical information is presented in Table 1 . A brief overview of the side effects reported by participants will be presented in the next section. Each participant took part in a face-to-face, semi-structured, indepth interview with a member of the research team. The bulk of the interviews were conducted by the lead researchers and 3 research assistants.
In average, interviews lasted between 45-90 minutes. At the beginning of the interview, participants were asked to describe their experience with antiretroviral drugs over time and how they impacted their life in general and on a day-to-day basis. Then, they were asked to describe their experience with side effects with a particular focus on the way side effects manifested themselves, how they made them feel, what they meant, and how they were managed. (21) , the research team needs to remain close to the data and open to other analytic possibilities. After establishing some strong analytic directions through initial lineby-line coding, we moved to categorization. Categorization essentially seeks to elevate the analysis on a more conceptual level. During this phase, each category and sub-category is constructed based on common patterns across multiple codes and common threads that describe what is happening in the data (21) .
Working with the emerging categories, we used a technique described by Paillé (25) : take unmarked transcriptions and write the categories in the margins as opposed to the codes identified in the earlier phase of the analysis. This technique not only helped to solidify emerging categories but it also ensured that meaningful content was not left out during the categorization process.
Finally, we moved to the last step of analysis by linking categories together -to move from a static position to a dynamic one (21) . This process allowed us to develop a visual representation of the experience of side effects (see Figure   1 ) and identify theoretical openings in our findings. For the purpose of this paper, we will focus exclusively on the empirical findings.
The theoretical openings identified during the analysis will be discussed more explicitly in a subsequent publication.
Results
On average, participants were born between 1960 and 1969 (66%). Most of the participants were male (74%). Female participants accounted for 24% of the sample. The vast majority of participants had an annual income below $30,000 CAN (86%). This is consistent with Marilou Gagnon, Dave Holmes sociodemographic profiles reported in previous studies (13) (14) (26) (27) . 14 participants had a high school diploma, 14 had a college degree, and 11 had a university degree (including undergraduate and graduate levels). The year of diagnosis was distributed as such within the group: 9 participants (18%) had been diagnosed prior to 1990, 14 (28%) between 1990 and 1994, 9 (18%) between 1995 and 1999, and 18 (36%) after 2000.
The year of diagnosis is important to consider in this study because it gives us an indication of the antiretroviral drugs that participants were first exposed to. Some participants (14) Table 1 ). During the analysis, three main categories emerged from the data: 1) the side effects, 2) the experience, and 3) the connections (see Figure   1 ). The first category suggests that we need to change how we think about side effects in order to take into account the context in which they are experienced, the different types of side effects, and the nature of the side effect experience. The second category puts forward the idea that the experience of side effects is composed of three 
Category 1: The Side Effects
The context (defined here as the historical and treatment contexts) in which participants first experienced and continued to experience side effects as well as the types and nature of side effects were identified as key sub-categories during the analysis. Each one will be briefly presented in the next sections.
Context
Our The idea that some side effects were only temporary encouraged participants to continue
"So far it's been choosing which side effects i want or i can deal with": a grounded theory of the hiv treatment side effects among people living with hiv
taking antiretroviral drugs and push through the "adjustment period". This idea was also reinforced through interactions with health care providers during which side effects such as diarrhea, bloating, nausea, vomiting, somnolence, fatigue, and grogginess were commonly described as "part of the package". It was generally recognized that most side effects are no static; they change from one day to another and evolve over a longer period of time (weeks and months). Because of this, they were considered to be somewhat unstable. Not knowing how they would feel from one day to the next put participants in a challenging situation, especially when it came to their family, work and volunteer obligations. 
Category 2: The Experience
At the core of the experience of side effects, we found three interrelated processes: becoming with, living with, and dealing with. For the purpose of this paper, we will go through a detailed description of each process separately.
However, it is important to point out that the three processes work together to shape the experience of side effects.
Becoming with
Throughout the interviews, we found that the experience of side effects was described as a process of becoming as opposed to a state of being. In other words, it was a process through which participants came to experience themselves as both healthy and sick. It was also a process through which participants became other versions of themselves and redefined their "normal". These three sub-categories will be further explored in the next sections. In the process of becoming healthy (as defined above), participants also became sick.
It was difficult for participants to make sense of this contradictory experience. On one hand, they were told by health care providers that they were healthy and managed to achieve a certain level of health on "paper". On the other hand, they felt sicker than ever before and had poor quality of life. This tension was highlighted by the following participant when she said: The process of becoming sick through the experience of side effects was common to all participants. Not only did side effects make them feel sick, but it also turned them into "sick people" with particular obligations, needs, and limitations. The next quote supports this: Side effects also acted as a constant reminder of being sick. Many participants mentioned during the interview that HIV did not make them feel sick or remind them of being sick.
It is through the experience of side effects that HIV materialized and became real for them. One participant clearly explained it when he said that "the greatest side effect is psychological because he was reminded every day that he was infected" (Informant 9, lines 259-260). Overall, the process of becoming sick was very hard on participants.
When we interviewed this participant, he struggled to contain his emotions when he said the following: The first thing I realize is that feeling of stunned a few hours after I take them. It Many participants offered similar descriptions of their day to day experiences while others emphasized that antiretroviral drugs took over (or dominated) their life the moment they developed side effects. There was a general consensus that you cannot live the life you want when you have side effects. As such, you have to adapt to a new way of life and learn to "live with it" -an expression used by many participants along with related terms such as "adjust", "adapt", "accept", "bear with", "get used to", "endure", and so forth.
Uh, [side effects], it's a chronic condition. I mean, you, you get used to it, it becomes your new normal. Um, like somebody asked me, I don't know who it was, some doctor asked me a few days ago "Do you get... are you tired or, yes, you... how much fatigue?" I'm like, "Well, I'm, I'm kind of always fatigued... but I've been living with that for a number of years, you know". So it is your new normal […] So it's, it's a chronic thing, you know. (Informant 8, lines 930-940).

Living with
just the flavour of stuff […]. And then, probably around 1:00, anywhere in the mid-afternoon, I'm just zomped […]. I need to take a nap. I really do, even if it's for an hour and then I'll feel better, but it feels like I'm just, uh, worn out and I know it's from the pills. I mean, I'm living with this. So, what happens, I take a nap. It takes me too now into the evening time... dinner time, I will eat […] I feel
Learning to "live with it" was considered to be the only option, the only way to stay alive by continuing to take antiretroviral drugs and not letting side effects completely take over your life to the point of not wanting to live anymore.
Learning to "live with it" was, in fact, the only way to regain some control over the powerful Living with side effects also involved a great deal of uncertainty. Participants faced uncertainty in their day-to-day life because of the unpredictable and unstable nature of side effects (as previously described in category 1).
Not knowing what will happen from one day to the next was a recurrent theme throughout the interviews. Living with side effects meant that participants had to live "day by day" which limited their ability to seek employment, engage in volunteer work, take part in social activities, and plan activities of daily living. Living "day by day" also meant that some days were good, some days were bad, and some days were simply too much to bear as suggested by the following quote.
So I'm living it, I'm living it day by day. Um, I have bouts of depression about it every... or, um, every now and then. (Informant 16, lines 256-258).
Not knowing what the future had to bring was another recurrent theme throughout the 
And, right now, I'm on this brand new thing [medication]. So it's this, it's like a roller coaster. I'm not sure what's coming. And that makes me a little nervous. (Informant 15 lines 359-361).
Living with side effects was challenging because of the uncertainties involved in taking antiretroviral drugs that cause a range of side effects -some more subtle "So far it's been choosing which side effects i want or i can deal with": a grounded theory of the hiv treatment side effects among people living with
Dealing with
The process of "dealing with" emerged as a core component of the experience of side effects.
Participants primarily focused on the various ways in which they tried to deal with side effects and the specific strategies they used. However, they also explained how side effects impacted their way of dealing with the treatment and why dealing with their HIV physician became so central to their experience. These three subcategories will be discussed below. Overall, dealing with side effects was not an easy process. Many participants described it as trial and error because they were never really certain about the best ways to manage their side effects and were left to figure this out on their own with very little support from providers: 
"So far it's been choosing which side effects i want or i can deal with": a grounded theory of the hiv treatment side effects among people living with hiv
Dealing with HIV physicians was challenging for the majority of participants. Not only did they struggle to have their side effects recognized and managed, but they also found it difficult to get their views heard without coming up against the hegemonic discourse on treatment and its benefits (including its life-saving benefits as illustrated by the quote below). Through their interactions with HIV physicians, they came to realize that side effects are simply not a priority -staying on treatment and achieving clinical outcomes are. As a result, they felt that side effects were normalized, minimized, dismissed, ignored and even ignored by their physicians. To sum up, it was obvious that participants could not deal with side effects with some success without dealing with their HIV physician first and the treatment second. This further complicated the experience of side effects and made it a more challenging experience overall.
Category 3: The Connections
The last category specifically addressed the second and third objectives of the study. It emerged from the same data as other categories, the only difference being that the analysis was more clearly focused on "connections". Three types of connections were identified and will be discussed next: connections with people, things and systems.
People
During the analysis, we found that side effects created new connections between participants and three distinct groups of people: medical specialists, specialized health care providers and peers. Because side effects impacted multiple body systems, it was not uncommon for participants to be refereed to medical specialists. Participants were referred to nutritionists to deal with side effects such as diabetes and hypercholesterolemia as well to alleviate gastrointestinal side effects such as diarrhea, anorexia, and bloating. They were also referred to physiotherapists to assist with pain and reduced mobility. Access to physiotherapy was an issue raised by participants who were told by their HIV physician that they needed it but did not have coverage for it. Peers 
Systems
The analysis revealed that participants were connected to three distinct systems which were influential in shaping their experience with side effects: the knowledge systems, the health care system, and the state welfare system. Building on the findings presented thus far, we identified two In their interactions with the health care system, participants who became more assertive and demanded answers, solutions, or even a change in physician were labelled and treated as "difficult, problematic or aggressive patients".
This was clearly explained by one participant whose physician failed to mention that his current treatment regimen could cause diabetes.
After he raised this point with his physician and expressed his discontent with the fact that this information was not shared with him, he was subsequently told to go see a psychiatrist because he had a "temper" (Informant 29, line 819). Being closely connected with the health care systems did not necessarily help participants with their side effects. In fact, it often created more problems or more frustrations as suggested above.
All of the participants had strong ties to the state welfare system as a direct result of their side effects. The majority of participants could no longer hold a full-time job which left them in a precarious financial situation with low income or no income at all. For this reason, they had to rely on state programs for financial assistance with living expenses and coverage of prescription drugs, dental services and vision care. Many participants also relied on subsidized housing programs or housing facilities for PLWH in addition to community-based programs that provided access to nutritious food and supplements. While they were grateful for the support and assistance, participants also felt "stuck" within this welfare system. This participant explains: With the support of disability assistance programs, some participants managed to "get out of the system" and hold a part-time job while also maintaining full coverage of their prescription drugs. For many participants, however, the fluctuating nature of their side effects did not allow them to consider that option. They had no choice but to remain "in the system". 
Discussion
This study is, to our knowledge, the first one to explore and describe the experience of side effects from the perspective of PLWH.
Our findings suggest that side effects are more complicated than they seem. The first step in broadening our understanding of side effects is to pay closer attention to the context in which they occur and how they manifest themselves. The second step in broadening our understanding and subsequently improving our response to side effects is to recognize that every person is unique. Every person has their own story to tell and their experience is far more complex than a checklist of symptoms. This experience will forever change who they are and how they see themselves, it will challenge their own assumptions about health and illness, and it will redefine what normal feels like. This experience is something they will have to live with every day for the rest of their lives. It will impact their body and their mind. As a result, it will set limits on what they can do, where they can go, who they can be, and how they can engage with others.
They will live in a constant state of fluctuation and uncertainty due to the nature of side effects.
Dealing with this experience will not be easy. It will involve a lot of research, experimentation, negotiation, planning, discussion, frustration, and unanswered questions. At the end, it will all come down to medications: taking more medications to solve a problem created by medications in the first place. This experience will raise questions about what we know and how we know. It will expose issues with the way pharmaceutical companies produce knowledge on side effects and how this impacts clinical practice. It will also create opportunities for new ways of knowing to emerge based on lived experience. Through this experience, they will develop strong ties to the health care and welfare systems. At times, this will make them feel supported. Other times, it will make them feel trapped.
The third and final step is not about understanding or improving our response to side effects. It is about demanding change: a change in discourse and a change in culture.
The study findings clearly suggest that a change is needed to ensure that side effects are part of the discourse on HIV treatment, instead of being erased from it. In recent years, this discourse has become increasingly focused on the idea that HIV treatment is now simpler, more manageable, better tolerated, less toxic, and more effective.
As suggested by the study findings, participants were feeling the effect on this discourse every time they interacted with health care providers.
It reduced their chances of being heard, being taken seriously, and being cared for. Unless we change the discourse on HIV treatment, it is unlikely that these issues will be addressed anytime soon. A change in culture was also identified as a priority in this study. The culture of silence that prevails in clinical settings further exacerbated the problems faced by participants.
Because of this culture, side effects were not discussed, assessed and properly managed, treatment benefits were amplified to the point of invalidating all concerns related to side effects, and people who experience side effects were repeatedly silenced by health care providers. This culture has not been challenged to date in the field of HIV.
Conclusion
In conclusion, we want to insist on the fact that side effects are a real concern as they continue to affect PLWH in so many ways. The findings of this study are particularly important at this point in time in the field of HIV because antiretroviral drugs are now considered to be the cornerstone of the response to the HIV epidemic. It is our hope that side effects will find their way back into the conversation as more and more people are being put on treatment (including HIV-negative people) and encouraged to start treatment at the time of diagnosis. It is our contention that there can be no conversation on treatment expansion without a real conversation on the intended and unintended effects of this treatment.
